Gemseki Investment

Profile and portfolio

Parent SNBL (Shin Nippon Biomedical Laboratories)HQ Tokyo, JapanFounded 2020

Gemseki Investment is the corporate venture arm of SNBL (Shin Nippon Biomedical Laboratories), a pharmaceutical and biotech company. It was founded in 2020 and is based in Tokyo, Japan. It invests at the seed stage. Sectors it names: healthcare and digital health, biotech and life sciences.

Companies backedS3: 9

Every figure links to its source

Snapshot

Investment stage: Seed to Seed

Data behind this graphic

Data behind this graphic
Item	Value
Stage range	Seed to Seed
Sectors	Healthcare and digital health, Biotech and life sciences
Geography	North America, Asia
Offices	Tokyo, Japan

Sources: S2 Gemseki Investment: fund overview; S3 Gemseki Investment: portfolio.

Scale and capital allocated

Data behind this graphic

Data behind this graphic
Measure	Value	Unit	Kind	Source
Companies backed	9	companies	Stated by the firm	S3
Companies on the firm's portfolio page	9	companies	Counted from the firm's own list	S3

Sources: S3 Gemseki Investment: portfolio.

Where it invests and who leads it

Geography

Headquarters: Tokyo, Japan
Offices: Tokyo, Japan

Investment regionsS2 S3

LeadersS5 S4

Hideyuki HiramaruRepresentative (CEO), GemsekiFind on LinkedIn Firm page
Yoshiharu AsanumaExecutive Officer, SNBL; Head of SGG DivisionFind on LinkedIn Firm page
Mika YasudaChief Specialist (Shuseki), License Support GroupFind on LinkedIn Firm page
Masami KusakaCounselor (Sanyo), License Support GroupFind on LinkedIn Firm page

Gemseki Investment on LinkedIn

Key facts

Fact	Value	Status	Source
Parent company	SNBL (Shin Nippon Biomedical Laboratories)	Single source	S5
Parent industry	Pharmaceuticals and biotech	Single source	S5
Founded	2020	Single source	S5
Headquarters	Tokyo, Japan	Single source	S5
Status	Active	Single source	S1
Capital source	Parent company only	Single source	S2
Companies backed	9	Single source	S3
Stages	Seed (inferred from announced rounds)	Estimate	S2

Fund vehicles

Vehicle	Size	Year	Source
Gemseki Investment LLP (fund 1)	JPY 1.1bn	2020	S5
Gemseki No.2 Investment LLP	Not published	2024	S6

Portfolio

The firm's portfolio page lists 9 companies.S3

Shared portfolio with other corporate VCs

1 companies on the Gemseki Investment portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

Firm	Shared	Companies in common
Daiwa Corporate Investment	1	CardioIntelligence
Shizuoka Capital	1	CardioIntelligence
Tokai Tokyo Investment	1	CardioIntelligence

Companies backed by the most corporate VCs

Every company on the Gemseki Investment list

9 companies, as listed on the firm's own website.S3 Read the firm's list.

AdipoSeeds
Alivas
CardioIntelligence
Cytonus Therapeutics
Juro Sciences
PRISM BioLab
Raise the Flag
Scohia Pharma
Tregem Biopharma

History

2017Gemseki established as SNBL subsidiary (business development platform)S5
2020Gemseki LLP fund of JPY 1.1 billion establishedS5

Official pages

Read the firm's own pages for current information.

Website www.gemseki-inv.com/
Portfolio www.gemseki-inv.com/portfolio/

Sources

S1Gemseki Investment: homeFirm
S2Gemseki Investment: fund overviewFirm
S3Gemseki Investment: portfolioFirm
S4SNBL-Gemseki Business Division: membersFirm
S5SNBL (Shin Nippon Biomedical Laboratories): start of investment business at subsidiary Gemseki (2020-10-21)Parent company
S6SNBL timely disclosure (JPX): corporate split of Gemseki investment business and merger (2024-07-30)Parent company

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Gemseki Investment or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.

Report a correction